Barcelona Respiratory Network ReviewsAcute bronchitis is a transient inflammation of the lower airways, most often caused by viral infections, and typically presents with a persistent cough lasting two to three weeks.
Marta Andreu +3 more
doaj +8 more sources
The conceptualization of acute bronchitis in general practice – a fuzzy problem with consequences? A qualitative study in primary care [PDF]
BMC Primary Care, 2023 Background Acute bronchitis is one of the most frequent diagnoses in primary care. Scientifically, it is conceptualized as a viral infection. Still, general practitioners (GPs) often prescribe antibiotics for acute bronchitis.
Nadine Schubert +2 more
doaj +2 more sources
Outpatient prescribing pattern for acute bronchitis in primary healthcare settings in China [PDF]
npj Primary Care Respiratory Medicine, 2021 Inappropriate prescribing for acute bronchitis in primary healthcare settings (PHSs) is commonly seen worldwide. Here we describe the prescribing patterns and antibiotic use for acute bronchitis in PHSs across China.
Mengyuan Fu +6 more
doaj +2 more sources
The impacts of air pollution on daily hospitalizations for acute bronchitis in children: a perspective from the coastal city of Shantou, China [PDF]
Frontiers in Public HealthBackgroundThe purpose of this study was to explore the impacts of ambient air pollution on daily hospitalizations for acute bronchitis in children from a coastal city perspective in China, and to further investigate the related susceptible populations ...
Junduo Chen +3 more
doaj +2 more sources
Efficacy and safety of Tanreqing oral liquid in treatment of acute bronchitis: study protocol for a randomized controlled trial [PDF]
Trials, 2022 Background Approximately 5% of adults have an episode of acute bronchitis each year, accounting for more than 10 million medical visits yearly. The primary goal of treatment is reduction of symptoms.
Guilan Cheng +3 more
doaj +2 more sources
Prescription of EPs 7630 is associated with short- and long-term benefits in acute bronchitis: a real-world data analysis [PDF]
Frontiers in PharmacologyIntroductionAcute bronchitis is caused by an infection of the lower respiratory tract, resulting in considerable distress of patients and substantial economic costs due to lost workdays.
Adrian Gillissen +5 more
doaj +2 more sources
Investigation into the Effectiveness of an Herbal Combination (Angocin®Anti-Infekt N) in the Therapy of Acute Bronchitis: A Retrospective Real-World Cohort Study [PDF]
AntibioticsBackground: The goal of this study was to evaluate whether the medical recommendation of Angocin®Anti-Infekt N (heretofore referenced as Angocin®) on the day of diagnosis of acute bronchitis is negatively associated with the recurrence of acute ...
Nina Kassner +4 more
doaj +2 more sources
The efficacy and safety of DW1601 in patients with acute bronchitis: a multi-center, randomized, double-blind, phase III clinical trial [PDF]
The Korean Journal of Internal Medicine, 2022 Background/Aims DW1601, an oral fixed dose combination syrup composed of DW16011 and Pelargonium sidoides, was developed to enhance the symptom relief effect in patients with acute bronchitis.
Young Seok Lee +7 more
doaj +2 more sources
HL301 in the treatment of acute bronchitis: a phase 2b, randomized, double-blind, placebocontrolled, multicenter study [PDF]
The Korean Journal of Internal Medicine, 2020 Background/Aims There is insufficient quality data to recommend the use of herbs for the treatment of acute bronchitis. Small number of randomized trials of plant extracts for this purpose were determined to be low quality and there are concerns for the ...
Sang Won Yoon +7 more
doaj +2 more sources
Acute bronchitis: clinical guidelines
Медицинский совет, 2020 The article deals with the issues of epidemiology and pharmacotherapy of acute bronchitis in adults. Acute bronchitis is one of the most pressing challenges in modern pulmonology, which is associated with a high incidence reaching 30–40 ‰ every year. The
A. A. Zaitsev
doaj +1 more source